Recent setbacks in measles elimination: the importance of investing in innovations for immunizations
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Recent setbacks in measles elimination: the importance of investing in innovations for immunizations
  • Published Date:

    February 20 2020

  • Source:
    Pan Afr Med J. 2020; 35(Suppl 1)
  • Language:
    English
Filetype[PDF-214.50 KB]


Details:
  • Alternative Title:
    Pan Afr Med J
  • Personal Author:
    Goodson, James L.
  • Description:
    The recent setbacks in efforts to achieve measles elimination goals are alarming. To reverse the current trends, it is imperative that the global health community urgently intensify efforts and make resource commitments to implement evidence-based elimination strategies fully, including supporting research and innovations. The Immunization Agenda 2030: A Global Strategy to Leave No One Behind (IA2030) is the new global guidance document that builds on lessons learned and progress made toward the GVAP goals, includes research and innovation as a core strategic priority, and identifies measles as a "tracer" for improving immunisation services and strengthening primary health care systems. To achieve vaccination coverage and equity targets that leave no one behind, and accelerate progress toward disease eradication and elimination goals, sustained and predictable investments are needed for the identified research and innovations priorities for the new decade.
  • Subject:
  • Pubmed ID:
    32373266
  • Pubmed Central ID:
    PMC7196335
  • Document Type:
    Journal Article
  • Collection(s):
    CDC Public Access
  • Main Document Checksum:
  • File Type:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.40 MB]
    Personal Author:
    Fiebelkorn, Amy Parker; Redd, Susan B.; Gastañaduy, Paul A.; Clemmons, Nakia; Rota, Paul A.; Rota, Jennifer S.; Bellini, William J.; Wallace, Gregory S.;
    Published Date:
    Mar 01 2017
    Source:
    J Pediatric Infect Dis Soc. 6(1):40-48.
    Description:
    BackgroundMeasles, a vaccine-preventable disease that can cause severe complications, was declared eliminated from the U.S. in 2000. The last published summary of U.S. measles epidemiology was during 2001−2008. We summarized U.S. measles epidemiolo...
    File Type:
    Filetype[PDF - 1.40 MB]
  2. Filetype[PDF - 4.70 MB]
    Personal Author:
    Khetsuriani, Nino; Sanadze, Ketevan; Chlikadze, Rusudan; Chitadze, Nazibrola; Dolakidze, Tamar; Komakhidze, Tamta; Jabidze, Lia; Huseynov, Shahin; Ben Mamou, Myriam; Muller, Claude; Zakhashvili, Khatuna; Hübschen, Judith M.;
    Published Date:
    Nov 2020
    Source:
    Emerg Infect Dis. 26(11):2565-2577
    Description:
    Controlling measles outbreaks in the country of Georgia and throughout Europe is crucial for achieving the measles elimination goal for the World Health Organization's European Region. However, large-scale measles outbreaks occurred in Georgia during...
    File Type:
    Filetype[PDF - 4.70 MB]
  3. Filetype[PDF - 234.11 KB]
    Personal Author:
    Johnson, Emery A.
    Published Date:
    Sep 1981
    Source:
    Public Health Rep. 96(5):i2
    File Type:
    Filetype[PDF - 234.11 KB]
  4. Filetype[PDF - 520.93 KB]
    Personal Author:
    Brandt, Edward N.
    Published Date:
    Jul 1982
    Source:
    Public Health Rep. 97(4):i2
    File Type:
    Filetype[PDF - 520.93 KB]
  5. Filetype[PDF - 155.13 KB]
    Personal Author:
    Koop, C. Everett
    Published Date:
    Nov 1982
    Source:
    Public Health Rep. 97(6):i2
    File Type:
    Filetype[PDF - 155.13 KB]